AHMEDABAD, 4 FEB 2023: Two local pharmaceutical companies have been restrained from manufacturing and marketing a drug for Type 2 diabetes after a German pharma giant claimed they had infringed on its patent rights. 

The case involves Germany's Boehringer Ingel......
View Details

Related News

• Supplying fake medicines for eight months, four arrested (25-09-2023)

---

• Firozpur STF arrested drug smuggler with 1100 intoxicating pills (25-09-2023)

---

• Varanasi, 84 stockists did business worth crores by creating dummy firms (25-09-2023)

---

• Gujarat FDCA attributes 45% of drug samples failing quality tests due to dissolution testing (25-09-2023)

---

• CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)

---

• Govt in process of identifying additional regulatory interventions to stop Misuse of Antimicrobials (25-09-2023)

---

• Resistance to last-resort antibiotics Carbapenem growing in India: ICMR report (25-09-2023)

---

• 4 arrested with 375 bottles of Eskuf cough syrup worth Rs 4 lakh (25-09-2023)

---

• Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)

---

• Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)

---